BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• 

  MASH

  Aligos Claims Mid-Stage Win in MASH but Investors Are Skeptical

  An unusual placebo effect in Aligos Therapeutics’ Phase IIa trial is driving shareholder skepticism for its metabolic dysfunction-associated steatohepatitis candidate, according to Jefferies analyst Michael Yee.

  September 20, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Multiple sclerosis

  Sanofi’s Tolebrutinib Delays MS Progression in Phase III Study Following Earlier Flops

  The positive readout in patients with non-relapsing secondary progressive multiple sclerosis comes on the heels of back-to-back failures in which tolebrutinib was unable to improve relapse rates in patients with relapsing MS.

  September 20, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Cancer

  ADCs, Bispecifics and Radiopharma Take Center Stage at ESMO24

  The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer treatment—antibody-drug conjugates, bispecifics and radiopharmaceuticals—while anti-TIGIT therapies made a bit of a comeback.

  September 20, 2024

   · 

  3 min read

   · 

  Greg Slabodkin
• 

  IRA

  Senate Bill Seeks to Spare Small Biotechs from IRA’s Drug Price Negotiations

  While unlikely to pass this year, given the Democrats’ control over the White House and Senate, the proposed legislation might be a harbinger of the Republicans’ agenda next year for the Inflation Reduction Act should they win the November elections.

  September 20, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Regulatory

  Novo Secures EU Panel’s Backing for Cardiovascular Use of Wegovy

  With Thursday’s positive opinion from the Committee for Medicinal Products for Human Use, the matter now heads to the European Commission which will have the final say on whether Wegovy’s label will be updated.

  September 20, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Weight Loss

  Novo’s Next-Gen CB1 Drug Leads to Weight Loss in Phase II, but Neuropsychiatric Events Reported

  Novo Nodrisk’s cannabinoid receptor–targeting obesity pill was picked up in the $1.1 billion acquisition of Inversago Pharmaceuticals last year.

  September 20, 2024

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

  September 20, 2024

   · 

  7 min read
• Press Releases

  Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts on ESMO 2024 Annual Meeting

  September 20, 2024

   · 

  2 min read
• Press Releases

  Laurel K. Leslie, MD, MPH, Named Director of the Mental and Behavioral Health Institute at Cincinnati Children’s

  September 20, 2024

   · 

  5 min read
• Press Releases

  Acumen Health Holdings (“Acumen”) to Acquire the Avenova brand from NovaBay Pharmaceuticals

  September 20, 2024

   · 

  2 min read